Regeneron Pharmaceuticals (REGN): Sen. Tommy Tuberville disclosed a purchase $1K–$15K
Sen. Tommy Tuberville disclosed a purchase of Regeneron Pharmaceuticals in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 116 days
- Disclosure lag
- Traded
- Mar 29, 2021
- Disclosed
- Jul 23, 2021
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 11, 2021CongressDisclosed purchase of REGN — reported range $1,001 - $15,000
- Mar 29, 2021 · this disclosureCongressDisclosed purchase of REGN — reported range $1,001 - $15,000
What came next
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Regeneron Pharmaceuticals
For Regeneron Pharmaceuticals, OQRO holds 73 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its REGN page.
Other recent filings by Sen. Tommy Tuberville
- Senate eFD periodic transaction report at Alphabet (GOOGL)Aug 5, 2026
- Senate eFD periodic transaction report at Goldman Sachs (GS)Aug 5, 2026
- Senate eFD periodic transaction report at Mastercard (MA)Aug 5, 2026
- Senate eFD periodic transaction report at Apple (AAPL)Aug 5, 2026
- Senate eFD periodic transaction report at Apple (AAPL)Aug 5, 2026
The full history of Sen. Tommy Tuberville is on the profile page.
How this filing works
Explore the data
Other disclosures at Regeneron Pharmaceuticals
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
Everything OQRO holds on this company is on its REGN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data